@article{ajmcr20231121,
author={{Kuwae, Noriko and Yamasato, Masahiro},
title={Sacubtril/valsartan in HFpEF and Maintenance Hemodialysis},
journal={American Journal of Medical Case Reports},
volume={11},
number={2},
pages={14--15},
year={2023},
url={http://pubs.sciepub.com/ajmcr/11/2/1},
issn={2374-216X},
abstract={The purpose of this report is to describe effectiveness and tolerability of medical treatment with sacubitril/valsartan in a patient treated with hemodialysis. We describe the case of a 68-year-old man with heart failure with ejection fraction more than 60%, that is HFpEF undergoing hemodialysis. He had several times heart failure due to diastolic dysfunction, he could tolerate a dose of 50/50mg, total 100mg daily. After initiation of sacubitril/valsartan, there was a symptomatic improvement with clear reduction NT-proBNP, left atrial dimension, E/e¡¯ as well as EF. In conclusion, in this patient with diastoric dysfunction undergoing hemodialysis, treatment with sacubitril/valsartan was effective, safe, and improved heart failure symptoms.},
doi={10.12691/ajmcr-11-2-1}
publisher={Science and Education Publishing}
}